Pay attention to infections in COVID-19 patients with underlying immune defect! https://t.co/fqcSNkrf6O Saade #Pneumoniae #COVID-19 #ICU #AIC #FICS #SRLF https://t.co/Y0HpwQFP0j
RT @of_aic: Pay attention to infections in COVID-19 patients with underlying immune defect! https://t.co/cTqBVgauf4 Saade #Pneumoniae #CO…
RT @of_aic: Pay attention to infections in COVID-19 patients with underlying immune defect! https://t.co/cTqBVgauf4 Saade #Pneumoniae #CO…
Pay attention to infections in COVID-19 patients with underlying immune defect! https://t.co/cTqBVgauf4 Saade #Pneumoniae #COVID-19 #ICU #AIC #FICS #SRLF https://t.co/WM9Lsb632c
3-5-2021: Paris, France, 100 patients "Dexamethasone was associated with increased infections (36% vs. 12%) at Day 10. After matching, dexamethasone was associated with hospital-acquired infections (35% vs. 13%) at Day 10 and had no influence on mortality"